+
Site Tour

Controversies in atrioventricular valves - Heart Team ring, Vol II

This session offers an opportunity to engage in a real case discussion led by an advanced Heart Team. Watch discussions on controversial decision-making scenarios and stay informed about the latest clinical evidence related to MitraClip, Tendyne, and TriClip therapies.

Related Videos

EuroPCR 2023: Mitral regurgitation

EuroPCR 2023: Vascular access

EuroPCR 2023: Defining the future

EuroPCR 2023: Tricuspid valve

EuroPCR 2023: COAPT 5-year follow-up

Navitor™: Voice of the Experts Maurizio Taramasso

LAAO Summit 2022: TEE

TAVI Case-Club – Alternative access

LAAO Summit 2022: Nephrology patient referral

Luca's testimonial

Navitor™: Voice of the Experts Mohammed Saad

AV VALVES 2023: TR – Atrial TR

Echo course PFO

TRENDING TOPICS

EACTS 2024 - Novel approaches for Valvular and LVAD therapies

Reconsidering current approaches to valve and LVAD therapies

Early outcomes on Epic Max platform

Cleveland clinic (US) experience: Early outcomes and a perspective on porcine vs. bovine

Transfemoral TAVI

Navitor Vision 35 implantation

CONNEXT


HUB
RELATED RESOURCES

ACC 2023: COAPT™ trial

PDA Patient Guide

EXPAND Study: Data overview

Epic Mitral – 10-Year Clinical Outcomes

CONNEXT


LIVE
RELATED EVENTS

EACVI Summit 2023: Congress symposium

TAVI 2023: The next level

LAAO Summit 2023: CT or no-CT?

LAAO Summit 2023: Leaks

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline